Autopsy report · NCT02150473
The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Cartilage in (RA) Patients
Cause of deathNo reason given
Life of this trial
- Registered 8 months before it started.
- Ran for about 2 years 11 months before it stopped.
- 21 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Heinrich-Heine University, Duesseldorf
- Sponsor type
- University, hospital or other
- Conditions
- Rheumatoid Arthritis
- Interventions
- Adalimumab; Placebo
- Participants
- 21
- Sites
- 1
- Countries
- Germany
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.